Endpoints News 9 feb 2026 #ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%
Endpoints News 9 feb 2026 Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages
Endpoints News 7 feb 2026 #ACTRIMS26: Sanofi unpacks data from a failed Phase 3 tolebrutinib trial in PPMS
Endpoints News 7 feb 2026 The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
Endpoints News 6 feb 2026 Geoff McDonough's big plans for NodThera's NLRP3; Enhertu leader steps down at Daiichi
Endpoints News 6 feb 2026 Roivant spinout Priovant touts Phase 2 brepocitinib data in cutaneous sarcoidosis